Robert Naclerio to Mast Cells
This is a "connection" page, showing publications Robert Naclerio has written about Mast Cells.
Connection Strength
0.722
-
Origin of late phase histamine release. J Allergy Clin Immunol. 1996 Oct; 98(4):721-3.
Score: 0.143
-
The effect of antihistamines on the immediate allergic response: a comparative review. Otolaryngol Head Neck Surg. 1993 Jun; 108(6):723-30.
Score: 0.114
-
In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy. 1989 Nov; 63(5):465-9.
Score: 0.089
-
Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
Score: 0.055
-
Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
Score: 0.034
-
Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
Score: 0.030
-
Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992 Jun; 89(6):1098-110.
Score: 0.027
-
Experimentally induced nasal allergic responses. J Allergy Clin Immunol. 1988 May; 81(5 Pt 2):940-9.
Score: 0.020
-
The pathophysiology of human mast cells. In vitro and in vivo function. Am Rev Respir Dis. 1987 May; 135(5):1196-200.
Score: 0.019
-
The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J. 1986 May; 65(5):206-12.
Score: 0.017
-
Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
Score: 0.017
-
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
Score: 0.017
-
The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986; 50 Suppl 2:116-22.
Score: 0.017
-
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
Score: 0.017
-
Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
Score: 0.017
-
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
Score: 0.016
-
Mast cells and mast cell mediators in models of airway disease. Prog Clin Biol Res. 1985; 199:153-61.
Score: 0.016
-
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 1):473-81.
Score: 0.016
-
IgE-mediated leukotriene release in vitro and in vivo. Trans Assoc Am Physicians. 1984; 97:260-7.
Score: 0.015
-
Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 01; 148(7):2223-8.
Score: 0.007
-
Pharmacology of upper airways challenge. Int Arch Allergy Appl Immunol. 1987; 82(3-4):493-7.
Score: 0.005
-
Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis. Am J Med. 1985 Dec 20; 79(6A):26-33.
Score: 0.004
-
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul; 76(1):191-7.
Score: 0.004
-
Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
Score: 0.004
-
The role of prostaglandin D2 in IgE-mediated reactions in man. Trans Assoc Am Physicians. 1982; 95:221-8.
Score: 0.003